DigitalX made advisor of world first blockchain & AI ecosystem

|

Published 15-MAR-2018 12:01 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

DigitalX Ltd (ASX:DCC) has been appointed corporate advisor to the world’s largest private Software as a Service (SaaS) email security company, MailGuard.

With the help of DCC’s advisory services, MailGuard will develop a world first blockchain cybersecurity ecosystem called GlobalGuard, which combines Artificial Intelligence (AI) and blockchain technology to identify emerging email-borne cyber threats.

The Melbourne-based MailGuard is a cloud email and cyber security company that services clients in 27 countries which has partnerships with high profile software providers including Microsoft. The AI algorithm used in the GlobalGuard system has been developed by MailGuard in collaboration with Deakin University in Melbourne.

“GlobalGuard will unite end-users, technology partners, cybercrime experts and vendors throughout the world on a living neural network, to identify and stop threats immediately. It is the next generation of cybersecurity and threat detection,” DigitalX CEO Leigh Travers said.

MailGuard CEO Craig McDonald added: “GlobalGuard will leverage the past seventeen years of MailGuard threat data and IP, in combination with an artificially intelligent neural network, trained to detect cybersecurity threats.

“The world’s largest companies and governments cannot win the war on cybercrime by acting alone. GlobalGuard will be the mechanism for real-time collaboration on the Blockchain to correct the imbalance of online cybercriminals,” Mr McDonald said.

Spending on cybersecurity products and services the world over is predicted to exceed $1 trillion by the year 2021, according to a report by Cybersecurity Ventures.

The collaboration announced today between MailGuard and DCC will be a significant step towards commercialising the GlobalGuard technology.

“Blockchain technology and AI is the new frontier in the fight against cybercrime. DigitalX is pleased to be involved with this project as GlobalGuard will connect a network of collaborators to identify and thwart cyber threats instantaneously,” Mr Travers said.

“DigitalX continues to strengthen our reputation for ICO advisory services and is now working with the world’s most promising Blockchain companies to help them deliver their vision.”

However, it’s worth noting that DCC is speculative at this stage and therefore investors should take all publicly available information into account and seek professional financial advice.

The GlobalGuard cybersecurity ecosystem is set to launch later in the year. Information in the lead up to the launch can be found at globalguard.io.

Today’s news follows on from DCC’s announcement earlier in the month, that it had been appointed corporate advisor for Shivom and Bankorus — both finalists in the Global Blockchain Competition.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X